Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Fractyl Health Inc (GUTS)

Fractyl Health Inc (GUTS)
1.1600 x 3 1.2200 x 1
Post-market by (Cboe BZX)
1.2200 +0.1100 (+9.91%) 04/17/25 [NASDAQ]
1.1600 x 3 1.2200 x 1
Post-market 1.2200 unch (unch) 19:56 ET
Quote Overview for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.1000
Day High
1.2300
Open 1.1100
Previous Close 1.1100 1.1100
Volume 314,600 314,600
Avg Vol 272,125 272,125
Stochastic %K 67.52% 67.52%
Weighted Alpha -76.81 -76.81
5-Day Change +0.2727 (+28.79%) +0.2727 (+28.79%)
52-Week Range 0.8730 - 7.8900 0.8730 - 7.8900
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 59,682
  • Shares Outstanding, K 48,920
  • Annual Sales, $ 90 K
  • Annual Income, $ -68,690 K
  • EBIT $ -81 M
  • EBITDA $ -81 M
  • 60-Month Beta 0.30
  • Price/Sales 583.88
  • Price/Cash Flow N/A
  • Price/Book 1.88

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.45
  • Number of Estimates 2
  • High Estimate -0.43
  • Low Estimate -0.47
  • Prior Year -0.75
  • Growth Rate Est. (year over year) +40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8730 +39.75%
on 04/10/25
Period Open: 1.2700
1.3300 -8.27%
on 03/24/25
-0.0500 (-3.94%)
since 03/17/25
3-Month
0.8730 +39.75%
on 04/10/25
Period Open: 1.8000
2.1850 -44.16%
on 01/27/25
-0.5800 (-32.22%)
since 01/17/25
52-Week
0.8730 +39.75%
on 04/10/25
Period Open: 6.6400
7.8900 -84.54%
on 05/24/24
-5.4200 (-81.63%)
since 04/17/24

Most Recent Stories

More News
Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation

GUTS : 1.2200 (+9.91%)
Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates

GUTS : 1.2200 (+9.91%)
Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025

GUTS : 1.2200 (+9.91%)
Fractyl Health Announces Increased Focus on Groundbreaking Revita® Weight Maintenance and Rejuva® Pancreatic Gene Therapy Programs with Potential to Deliver Key Clinical Milestones Across Multiple Studies in 2025

GUTS : 1.2200 (+9.91%)
Fractyl Health Announces Positive Initial Clinical Results Demonstrating Weight Maintenance Following GLP-1 Discontinuation and Revita Procedure in First Patient of the REVEAL-1 Cohort

GUTS : 1.2200 (+9.91%)
Fractyl Health Reports Successful Delivery of RJVA-001 in Yucatan Pig Models, Paving the Way for First-in-Human Studies in 2025

RJVA-001 demonstrated effective pancreatic targeting and GLP-1 expression with no safety issues in Yucatan pigs, supporting human trials in 2025.Quiver AI SummaryFractyl Health, Inc. has successfully delivered...

GUTS : 1.2200 (+9.91%)
Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local Delivery of RJVA-001 Rejuva® Smart GLP-1™ Pancreatic Gene Therapy at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)

GUTS : 1.2200 (+9.91%)
Fractyl Health to Present New Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)

GUTS : 1.2200 (+9.91%)
Fractyl Health to Participate in the Upcoming December Conferences

GUTS : 1.2200 (+9.91%)
Why This Penny Stock Lost 13% Last Week While Markets Soared

Traders sold the news on this biotech stock's conference update.

GUTS : 1.2200 (+9.91%)

Business Summary

Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including T2D and obesity. Fractyl Health is based in Lexington, MA.

See More

Key Turning Points

3rd Resistance Point 1.3967
2nd Resistance Point 1.3133
1st Resistance Point 1.2667
Last Price 1.2200
1st Support Level 1.1367
2nd Support Level 1.0533
3rd Support Level 1.0067

See More

52-Week High 7.8900
Fibonacci 61.8% 5.2095
Fibonacci 50% 4.3815
Fibonacci 38.2% 3.5535
Last Price 1.2200
52-Week Low 0.8730

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro